Catalyst Wire Dossier Catalyst Wire Dossier

ISONIAZID

ISONIAZID · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

75 regulatory and trial events tracked for ISONIAZID, covering 2007-08-08 to 2026-06-15. Get the full timeline:

Most recent: Clinical Trial Results: Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention [Phase 1]

See pricing